Positive outcome of End-of-Phase 2 meeting with U.S. Food and Drug Administration (FDA) in September 2023 enables advancement of BNC210 into Phase 3 studies in Social Anxiety Disorder Company confirms ...
If you have anxiety, know that you are not alone. Anxiety disorders are the most common form of mental illness in the United States. Anxiety disorders include, but are not limited to, post traumatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results